George E. Mark

2.5k total citations
54 papers, 1.5k citations indexed

About

George E. Mark is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Genetics. According to data from OpenAlex, George E. Mark has authored 54 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 19 papers in Cardiology and Cardiovascular Medicine and 14 papers in Genetics. Recurrent topics in George E. Mark's work include Virus-based gene therapy research (12 papers), Cardiac pacing and defibrillation studies (9 papers) and Monoclonal and Polyclonal Antibodies Research (9 papers). George E. Mark is often cited by papers focused on Virus-based gene therapy research (12 papers), Cardiac pacing and defibrillation studies (9 papers) and Monoclonal and Polyclonal Antibodies Research (9 papers). George E. Mark collaborates with scholars based in United States, United Kingdom and Italy. George E. Mark's co-authors include Ulf R. Rapp, Chitrananda Abeygunawardana, Tomás Maira‐Litrán, Gerald B. Pier, Joseph G. Joyce, Donald A. Goldmann, Andrea Kropec, Albert S. Kaplan, Andréa Pfeifer and John M. Taylor and has published in prestigious journals such as Nature, Science and Nucleic Acids Research.

In The Last Decade

George E. Mark

50 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
George E. Mark United States 22 861 262 216 212 208 54 1.5k
Michel Jolivet France 24 604 0.7× 368 1.4× 320 1.5× 632 3.0× 192 0.9× 64 1.8k
C. de Taisne France 11 885 1.0× 580 2.2× 271 1.3× 77 0.4× 144 0.7× 16 1.7k
Wilfred E. Marissen United States 22 997 1.2× 447 1.7× 344 1.6× 284 1.3× 181 0.9× 27 2.3k
Martin Schleef Germany 24 1.4k 1.6× 446 1.7× 299 1.4× 81 0.4× 321 1.5× 60 2.0k
Florence Colbère-Garapin France 25 975 1.1× 269 1.0× 425 2.0× 107 0.5× 201 1.0× 58 2.2k
E Fleissner United States 18 593 0.7× 405 1.5× 233 1.1× 220 1.0× 157 0.8× 33 1.4k
C B Cardellichio United States 12 310 0.4× 275 1.0× 261 1.2× 199 0.9× 247 1.2× 16 1.7k
Iyoko Katoh Japan 21 1.2k 1.4× 408 1.6× 201 0.9× 85 0.4× 616 3.0× 40 2.2k
Takuo Mizukami Japan 18 537 0.6× 422 1.6× 381 1.8× 94 0.4× 175 0.8× 67 1.4k
F. Hill United Kingdom 25 1.4k 1.7× 440 1.7× 326 1.5× 126 0.6× 137 0.7× 59 2.5k

Countries citing papers authored by George E. Mark

Since Specialization
Citations

This map shows the geographic impact of George E. Mark's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by George E. Mark with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites George E. Mark more than expected).

Fields of papers citing papers by George E. Mark

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by George E. Mark. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by George E. Mark. The network helps show where George E. Mark may publish in the future.

Co-authorship network of co-authors of George E. Mark

This figure shows the co-authorship network connecting the top 25 collaborators of George E. Mark. A scholar is included among the top collaborators of George E. Mark based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with George E. Mark. George E. Mark is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Oza, Saumil R., Anthony R. Magnano, Mark D. Metzl, et al.. (2024). PO-04-069 ACTIVE VS. PASSIVE ESOPHAGEAL PROTECTION STRATEGIES DURING RADIOFREQUENCY ABLATION OF ATRIAL FIBRILLATION: RESULTS FROM THE PROSPECTIVE REAL-AF REGISTRY. Heart Rhythm. 21(5). S483–S483. 1 indexed citations
2.
Mark, George E., et al.. (2022). Closure of Iatrogenic Atrial Septal Defect After Placement of Left Atrial Appendage Closure Device. JACC Case Reports. 4(16). 1053–1055.
3.
Gardner, Roy S., et al.. (2021). Real-World Outcomes in Cardiac Resynchronization Therapy Patients: Design and Baseline Demographics of the SMART- Registry. ESC Heart Failure. 8(2). 1675–1680. 6 indexed citations
4.
5.
Friedman, Lisa S., Kimberly Schadt, Sean R. Regner, et al.. (2012). Elevation of serum cardiac troponin I in a cross-sectional cohort of asymptomatic subjects with Friedreich ataxia. International Journal of Cardiology. 167(4). 1622–1624. 17 indexed citations
6.
Mark, George E., et al.. (2008). The ΔHA Value During Entrainment of a Long RP Tachycardia: Another Useful Criterion for Diagnosis of Supraventricular Tachycardia. Journal of Cardiovascular Electrophysiology. 19(5). 559–561. 4 indexed citations
7.
Greenspon, Arnold J., et al.. (2008). Lead‐Associated Endocarditis: The Important Role of Methicillin‐Resistant Staphylococcus aureus. Pacing and Clinical Electrophysiology. 31(5). 548–553. 40 indexed citations
8.
Chan, Christine P., et al.. (1999). Identification of linear surface epitopes on the guinea pig sperm membrane protein PH-20. Life Sciences. 64(22). 1989–2000. 5 indexed citations
9.
Tung, Jwu‐Sheng, Juan Antonio Giménez‐Bastida, Craig T. Przysiecki, & George E. Mark. (1998). Characterization of Recombinant Hepatitis B Surface Antigen Using Surface Plasmon Resonance. Journal of Pharmaceutical Sciences. 87(1). 76–80. 11 indexed citations
10.
Silberklang, Melvin, et al.. (1996). Rapid, High-Level Transient Expression of Papillomavirus-Like Particles in Insect Cells. BioTechniques. 20(5). 890–895. 5 indexed citations
11.
Gupta, Sunil, et al.. (1996). Molecular Cloning of the Human Fertilin β Subunit. Biochemical and Biophysical Research Communications. 224(2). 318–326. 35 indexed citations
12.
Lewis, Craig M., Gregory Hollis, George E. Mark, Jwu‐Sheng Tung, & Steven W. Ludmerer. (1995). Use of a novel mutagenesis strategy, optimized residue substitution, to decrease the off-rate of an anti-gp120 antibody. Molecular Immunology. 32(14-15). 1065–1072. 6 indexed citations
13.
Daugherty, Bruce L., Julie A. DeMartino, Ming-Fan Law, et al.. (1991). Polymerase chain reaction facilitates the cloning, CDRgrafting, and rapid expression of a murine monoclonal antibody directed against the CD18 component of leukocyte integrins. Nucleic Acids Research. 19(9). 2471–2476. 47 indexed citations
14.
Kasid, Usha N., et al.. (1989). Sensitivities of NIH/3T3-derived clonal cell lines to ionizing radiation: significance for gene transfer studies.. PubMed. 49(12). 3396–400. 35 indexed citations
15.
Pfeifer, Andrea M. A., John F. Lechner, Tohru Masui, et al.. (1989). Control of Growth and Squamous Differentiation in Normal Human Bronchial Epithelial Cells by Chemical and Biological Modifiers and Transferred Genes. Environmental Health Perspectives. 80. 209–209. 1 indexed citations
16.
Skouv, Jan, et al.. (1989). Malignant transformation of human bladder epithelial cells by DNA transfection with the v‐raf oncogene. Molecular Carcinogenesis. 2(2). 59–62. 7 indexed citations
17.
Brash, Douglas E., George E. Mark, Michael Farrell, & Curtis C. Harris. (1987). Overview of human cells in genetic research: Altered phenotypes in human cells caused by transferred genes. Somatic Cell and Molecular Genetics. 13(4). 429–440. 9 indexed citations
18.
Mark, George E., Ross MacIntyre, Mary Ellen Digan, Linda Ambrosio, & Norbert Perrimon. (1987). Drosophila melanogaster Homologs of the raf Oncogene. Molecular and Cellular Biology. 7(6). 2134–2140. 9 indexed citations
19.
Mason, William S., Maxine L. Linial, T W Hsu, et al.. (1982). Alterations in the genomes of avian sarcoma viruses. Virology. 117(2). 456–474. 7 indexed citations
20.
Soloff, Louis A., Jacob Zatuchni, & George E. Mark. (1957). MYOCARDIAL AND VALVULAR FACTORS IN RHEUMATIC HEART DISEASE WITH MITRAL STENOSIS. The American Journal of the Medical Sciences. 233(5). 518–527. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Michel Jolivet Breakdown of academic impact, for papers by C. de Taisne Breakdown of academic impact, for papers by Wilfred E. Marissen Breakdown of academic impact, for papers by Martin Schleef Breakdown of academic impact, for papers by Florence Colbère-Garapin Breakdown of academic impact, for papers by E Fleissner Breakdown of academic impact, for papers by C B Cardellichio Breakdown of academic impact, for papers by Iyoko Katoh Breakdown of academic impact, for papers by Takuo Mizukami Breakdown of academic impact, for papers by F. Hill
Rankless by CCL
2026